Plain-English translation of NCT05802186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to radiation therapy for lung cancer using artificial intelligence software (Deep Profiler + iGray) to help doctors personalize the radiation dose for each patient. Instead of using a standard dose for everyone, the AI analyzes your specific tumor and recommends a customized radiation dose that may work better for you. You'll receive stereotactic body radiation therapy (SBRT), a focused, high-precision form of radiation delivered over just a few sessions.
Standard radiation therapy uses the same dose for most patients, but every tumor is different. This trial exists to see whether letting artificial intelligence help customize the radiation dose to your individual tumor can reduce the chance of cancer coming back and improve your overall survival.
You likely qualify if…
You likely don't qualify if…
You will come in for radiation planning, during which doctors will use the AI software to map out your tumor and calculate a personalized radiation dose. You will then receive several sessions of focused radiation therapy over about one to two weeks. Throughout the study, you'll have follow-up imaging scans (CT, PET, or MRI) and visits to check how well the treatment worked and monitor for any side effects.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States